Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Robertson, JFR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 122 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cheung, KL; Robertson, JFR
      Preoperative hormone therapy trials for breast cancer

      BREAST
    2. Tan, SM; Cheung, KL; Willsher, PC; Blamey, RW; Chan, SY; Robertson, JFR
      Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy

      EUROPEAN JOURNAL OF CANCER
    3. Whitlock, JPL; Evans, AJ; Jackson, L; Chan, SY; Robertson, JFR
      Imaging of metastatic breast cancer: Distribution and radiological assessment at presentation

      CLINICAL ONCOLOGY
    4. Nabholtz, JM; Bonneterre, J; Buzdar, A; Robertson, JFR; Thurlimann, B; Steinberg, M; Webster, A; von Euler, M
      Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply

      JOURNAL OF CLINICAL ONCOLOGY
    5. Cheung, KL; Evans, AJ; Robertson, JFR
      The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy

      BREAST CANCER RESEARCH AND TREATMENT
    6. Kenny, FS; Willsher, PC; Gee, JMW; Nicholson, RI; Pinder, SE; Ellis, IO; Robertson, JFR
      Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    7. Cheung, KL; Nicholson, RI; Blamey, RW; Robertson, JFR
      Selection of primary breast cancer patients for adjuvant endocrine therapy- is oestrogen receptor alone adequate?

      BREAST CANCER RESEARCH AND TREATMENT
    8. Gee, JMW; Robertson, JFR; Ellis, IO; Nicholson, RI
      Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    9. Kenny, FS; Gee, JMW; Nicholson, RI; Ellis, IO; Morris, TM; Watson, SA; Bryce, RP; Robertson, JFR
      Effect of dietary GLA plus /-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts

      INTERNATIONAL JOURNAL OF CANCER
    10. Bonneterre, J; Buzdar, A; Nabholtz, JMA; Robertson, JFR; Thurlimann, B; von Euler, M; Sahmoud, T; Webster, A; Steinberg, M
      Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma - Results of two randomized trials designed for combined analysis

      CANCER
    11. Crombie, N; Rampaul, RS; Pinder, SE; Elston, CW; Robertson, JFR; Ellis, IO
      Extent of ductal carcinoma in situ within and surrounding invasive primarybreast carcinoma

      BRITISH JOURNAL OF SURGERY
    12. Cheung, KL; Howell, A; Robertson, JFR
      Preoperative endocrine therapy for breast cancer

      ENDOCRINE-RELATED CANCER
    13. Hui, R; Macmillan, RD; Kenny, FS; Musgrove, EA; Blamey, RW; Nicholson, RI; Robertson, JFR; Sutherland, RL
      INK4a gene expression and methylation in primary breast cancer: Overexpression of p16(INK4a) messenger RNA is a marker of poor prognosis

      CLINICAL CANCER RESEARCH
    14. Kollias, J; Macmillan, RD; Sibbering, DM; Burrell, H; Robertson, JFR
      Effect of evening primrose oil on clinically diagnosed fibroadenomas

      BREAST
    15. Jacobs, E; Bulpitt, PCA; Coutts, IGC; Robertson, JFR
      New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status

      ANTI-CANCER DRUGS
    16. Bonneterre, J; Thurlimann, B; Robertson, JFR; Krzakowski, M; Mauriac, L; Koralewski, P; Vergote, I; Webster, A; Steinberg, M; von Euler, M
      Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study

      JOURNAL OF CLINICAL ONCOLOGY
    17. Cheung, KL; Pinder, SE; Paish, C; Sadozye, AH; Chan, SY; Evans, AJ; Blamey, RW; Robertson, JFR
      The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    18. Cheung, KL; Graves, CRL; Robertson, JFR
      Tumour marker measurements in the diagnosis and monitoring of breast cancer

      CANCER TREATMENT REVIEWS
    19. Gee, JMW; Barroso, AF; Ellis, IO; Robertson, JFR; Nicholson, RI
      Biological and clinical associations of c-jun activation in human breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    20. Knowlden, JM; Gee, JMW; Robertson, JFR; Ellis, IO; Nicholson, RI
      A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    21. Yip, SS; Crew, AJ; Gee, JMW; Hui, R; Blamey, RW; Robertson, JFR; Nicholson, RI; Sutherland, RL; Daly, RJ
      Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression

      INTERNATIONAL JOURNAL OF CANCER
    22. Kenny, FS; Pinder, SE; Ellis, IO; Gee, JMW; Nicholson, RI; Bryce, RP; Robertson, JFR
      Gamma linolenic acid with tamoxifen as primary therapy tn breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    23. Evans, AJ; Robertson, JFR
      Magnetic resonance imaging versus radionuclide scintigraphy for screening in bone metastases

      CLINICAL RADIOLOGY
    24. Wilson, ARM; Evans, AJ; Robertson, JFR
      The missing mammographic abnormality

      BRITISH JOURNAL OF SURGERY
    25. Nicholson, RI; McClelland, RA; Robertson, JFR; Gee, JMW
      Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer

      ENDOCRINE-RELATED CANCER
    26. Kenny, FS; Hui, R; Musgrove, EA; Gee, JMW; Blamey, RW; Nicholson, RI; Sutherland, RL; Robertson, JFR
      Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer

      CLINICAL CANCER RESEARCH
    27. Kollias, J; Murphy, CA; Elston, CW; Ellis, IO; Robertson, JFR; Blamey, RW
      The prognosis of small primary breast cancers

      EUROPEAN JOURNAL OF CANCER
    28. Robertson, JFR; Willsher, PC; Winterbottom, L; Blamey, RW; Thorpe, S
      Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

      EUROPEAN JOURNAL OF CANCER
    29. Robertson, JFR; Jaeger, W; Syzmendera, JJ; Selby, C; Coleman, R; Howell, A; Winstanley, J; Jonssen, PE; Bombardieri, E; Sainsbury, JRC; Gronberg, H; Kumpulainen, E; Blamey, RW
      The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers

      EUROPEAN JOURNAL OF CANCER
    30. Vorobiof, DA; Kleeberg, UR; Perez-Carrion, R; Dodwell, DJ; Robertson, JFR; Calvo, L; Dowsett, M; Clack, G
      A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex (R)) with intramuscular formestane in postmenopausal women with advanced breast cancer

      ANNALS OF ONCOLOGY
    31. Robertson, JFR; Howell, A; Buzdar, A; von Euler, M; Lee, D
      Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    32. Gee, JMW; Robertson, JFR; Ellis, IO; Nicholson, RI; Hurst, HC
      Immunohistochemical analysis reveals a tumour suppressor-like role for thetranscription factor AP-2 in invasive breast cancer

      JOURNAL OF PATHOLOGY
    33. McClelland, RA; Gee, JMW; O'Sullivan, L; Barnes, DM; Robertson, JFR; Ellis, IO; Nicholson, RI
      p21(WAF1) expression and endocrine response in breast cancer

      JOURNAL OF PATHOLOGY
    34. Gonzalez, MA; Pinder, SE; Wencyk, PM; Bell, JA; Elston, CW; Nicholson, RI; Robertson, JFR; Blamey, RW; Ellis, IO
      An immunohistochemical examination of the expression of E-cadherin, alpha-and beta/gamma-catenins, and alpha 2- and beta 1-integrins in invasive breast cancer

      JOURNAL OF PATHOLOGY
    35. Seery, LT; Knowlden, JM; Gee, JMW; Robertson, JFR; Kenny, FS; Ellis, IO; Nicholson, RI
      BRCA1 expression levels predict distant metastasis of sporadic breast cancer (vol 84, pg 258, 1999)

      INTERNATIONAL JOURNAL OF CANCER
    36. Seery, LT; Knowlden, JM; Gee, JMW; Robertson, JFR; Kenny, FS; Ellis, IO; Nicholson, RI
      BRCA1 expression levels predict distant metastasis of sporadic breast cancers

      INTERNATIONAL JOURNAL OF CANCER
    37. Gee, JMW; Willsher, PC; Kenny, FS; Robertson, JFR; Pinder, SE; Ellis, IO; Nicholson, RI
      Endocrine response and resistance in breast cancer: A role for the transcription factor Fos

      INTERNATIONAL JOURNAL OF CANCER
    38. Jacobs, E; Watson, SA; Michaeli, D; Ellis, IO; Robertson, JFR
      Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7human breast cancer xenografts

      BRITISH JOURNAL OF CANCER
    39. JACOBS E; WATSON SA; HARDCASTLE JD; ROBERTSON JFR
      THE GROWTH-RATE OF HUMAN GASTROINTESTINAL CANCER CELL-LINES AS XENOGRAFTS RELATES TO THE SEX OF THE TUMOR-BEARING MICE

      GI cancer (Print)
    40. GRAVES R; HILGERS J; FRITSCHE H; HAYES D; ROBERTSON JFR
      MUC-1 MUCIN ASSAYS FOR MONITORING THERAPY IN METASTATIC BREAST-CANCER

      Breast
    41. Kenny, FS; Robertson, JFR; Ellis, IO; Elston, CW; Blamey, RW
      Long-term follow-up of elderly patients randomized to primary tamoxifen orwedge mastectomy as initial therapy for operable breast cancer

      BREAST
    42. KENNY FS; PINDER S; ELLIS IO; BRYCE RP; HARTLEY J; ROBERTSON JFR
      GAMMA-LINOLENIC ACID WITH TAMOXIFEN AS PRIMARY THERAPY IN BREAST-CANCER

      European journal of cancer
    43. KENNY FS; GEE JM; NICHOLSON RI; MORRIS T; WATSON S; BRYCE RP; HARTLEY J; ROBERTSON JFR
      EFFECT OF DIETARY GLA + - TAMOXIFEN ON GROWTH AND ER IN A HUMAN BREAST-CANCER XENOGRAFT MODEL/

      European journal of cancer
    44. KENNY FS; WILLSHER PC; GEE JMW; NICHOLSON RI; ELLIS IO; ROBERTSON JFR
      CHANGE IN EXPRESSION OF ER AND BCL-2 PREDICT FOR QUALITY AND DURATIONOF RESPONSE IN ENDOCRINE SENSITIVE BREAST-CANCER

      European journal of cancer
    45. HUI R; BALL JR; MACMILLAN RD; KENNY FS; PRALL OWJ; CAMPBELL DH; CORNISH AL; MCCLELLAND RA; DALY RJ; FORBES JF; BLAMEY RW; MUSGROVE EA; ROBERTSON JFR; NICHOLSON RI; SUTHERLAND RL
      EMS1 GENE-EXPRESSION IN PRIMARY BREAST-CANCER - RELATIONSHIP TO CYCLIN D1 AND ESTROGEN-RECEPTOR EXPRESSION AND PATIENT SURVIVAL

      Oncogene
    46. KNOWLDEN JM; GEE JMW; SEERY LT; FARROW L; GULLICK WJ; ELLIS IO; BLAMEY RW; ROBERTSON JFR; NICHOLSON RI
      C-ERBB3 AND C-ERBB4 EXPRESSION IS A FEATURE OF THE ENDOCRINE RESPONSIVE PHENOTYPE IN CLINICAL BREAST-CANCER

      Oncogene
    47. KENNY FS; PINDER S; ELLIS IO; BRYCE RP; HARTLEY J; ROBERTSON JFR
      GAMMA-LINOLENIC ACID WITH TAMOXIFEN AS PRIMARY THERAPY IN BREAST-CANCER - EARLY RESULTS OF A PHASE-II PILOT-STUDY

      Annals of oncology
    48. Willsher, PC; Pinder, SE; Gee, JMW; Ellis, IO; Chan, SY; Nicholson, RI; Blamey, RW; Robertson, JFR
      c-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer

      ANTICANCER RESEARCH
    49. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
      POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS

      Lancet
    50. ROBERTSON JFR; BLAMEY RW
      UNTITLED

      British Journal of Cancer
    51. KENNY FS; PINDER S; ELLIS IO; BRYCE RP; ROBERTSON JFR
      GAMMA-LINOLENIC ACID WITH TAMOXIFEN AS PRIMARY THERAPY IN BREAST-CANCER

      British Journal of Cancer
    52. MCCLELLAND RA; MANNING DL; GEE JMW; WILLSHER P; ROBERTSON JFR; ELLIS IO; BLAMEY RW; NICHOLSON RI
      ESTROGEN-REGULATED GENES IN BREAST-CANCER - ASSOCIATION OF PLIV1 WITHRESPONSE TO ENDOCRINE THERAPY

      British Journal of Cancer
    53. NICHOLSON RI; GEE JMW; HARPER ME; ELLIS IO; WILLSHER P; ROBERTSON JFR
      ERBB SIGNALING IN CLINICAL BREAST-CANCER - RELATIONSHIP TO ENDOCRINE SENSITIVITY

      Endocrine-related cancer
    54. KNOWLDEN JM; GEE JMW; BRYANT S; MCCLELLAND RA; MANNING DL; MANSEL R; ELLIS IO; BLAMEY RW; ROBERTSON JFR; NICHOLSON RI
      USE OF REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION METHODOLOGY TODETECT ESTROGEN-REGULATED GENE-EXPRESSION IN SMALL BREAST-CANCER SPECIMENS

      Clinical cancer research
    55. WHEATLEY DC; YEOMAN LJ; BURRELL H; PINDER SE; EVANS AJ; WILSON ARM; ELLIS IO; ELSTON CW; ROBERTSON JFR; BLAMEY RW
      MAMMOGRAPHIC AND PATHOLOGICAL FEATURES OF BREAST-CANCER DETECTED AT FIRST INCIDENT ROUND SCREENING

      Breast
    56. CONNOR AJM; PINDER SE; ELSTON CW; BELL JA; WENCYK P; ROBERTSON JFR; BLAMEY RW; NICHOLSON RI; ELLIS IO
      INTRATUMORAL HETEROGENEITY OF PROLIFERATION IN INVASIVE BREAST-CARCINOMA EVALUATED WITH MIB1 ANTIBODY

      Breast
    57. ROBERTSON JFR; HOWELL A; DEFRIEND DJ; BLAMEY RW; WALTON P
      DURATION OF REMISSION TO ICI-182,780 COMPARED TO MEGESTROL-ACETATE INTAMOXIFEN-RESISTANT BREAST-CANCER

      Breast
    58. WILLSHER PC; ROBERTSON JFR; JACKSON L; ALHILALY M; BLAMEY RW
      INVESTIGATION OF PRIMARY TAMOXIFEN THERAPY FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER

      Breast
    59. JACOBS E; WATSON SA; ELLIS IO; HARDCASTLE JD; ROBERTSON JFR
      THE EFFECT OF ONAPRISTONE, A PROGESTERONE ANTAGONIST, ON THE GROWTH OF HUMAN GASTROINTESTINAL CANCER XENOGRAFTS

      European journal of cancer
    60. ROBERTSON JFR; WILLSHER PC; CHEUNG KL; BLAMEY RW
      THE CLINICAL RELEVANCE OF STATIC DISEASE (NO CHANGE) CATEGORY FOR 6 MONTHS ON ENDOCRINE THERAPY IN PATIENTS WITH BREAST-CANCER

      European journal of cancer
    61. WILLSHER PC; ROBERTSON JFR; CHAN SY; JACKSON L; BLAMEY RW
      LOCALLY ADVANCED BREAST-CANCER - EARLY RESULTS OF A RANDOMIZED TRIAL OF MULTIMODAL THERAPY VERSUS INITIAL HORMONE-THERAPY

      European journal of cancer
    62. ROBERTSON JFR; LEE D
      STATIC DISEASE (SD) OF LONG-DURATION (GREATER-THAN-OR-EQUAL-TO-24 WEEKS) IS AN IMPORTANT REMISSION CRITERION IN BREAST-CANCER PATIENTS TREATED WITH THE AROMATASE INHIBITOR ANASTROZOLE (AN)

      European journal of cancer
    63. MCCARTHY DOB; BLAMEY RW; ROBERTSON JFR; MITCHELL AK
      A ONE-YEAR AUDIT OF 255 OPERABLE BREAST CANCERS

      European journal of surgical oncology
    64. ALHILALY M; WILLSHER PC; ROBERTSON JFR; BLAMEY RW
      AUDIT OF A CONSERVATIVE MANAGEMENT POLICY OF THE AXILLA IN ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER

      European journal of surgical oncology
    65. CHEUNG KL; BLAMEY RW; ROBERTSON JFR; ELSTON CW; ELLIS IO
      SUBCUTANEOUS MASTECTOMY FOR PRIMARY BREAST-CANCER AND DUCTAL CARCINOMA IN-SITU

      European journal of surgical oncology
    66. MURRAY A; WILLSHER P; PRICE MR; DIXON AR; ROBERTSON JFR
      EVALUATION OF THE IMMULITE(R) BR-MA AND CEA ASSAYS AND COMPARISON WITH IMMUNORADIOMETRIC ASSAYS FOR CA15-3 AND CEA IN BREAST-CANCER

      Anticancer research
    67. WILLSHER PC; LEACH LH; ELLIS IO; BELL JA; ELSTON CW; BOURKE JB; BLAMEY RW; ROBERTSON JFR
      MALE BREAST-CANCER - PATHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES

      Anticancer research
    68. CHEUNG KL; WILLSHER PC; PINDER SE; ELLIS IO; ELSTON CW; NICHOLSON RI; BLAMEY RW; ROBERTSON JFR
      PREDICTORS OF RESPONSE TO 2ND-LINE ENDOCRINE THERAPY FOR BREAST-CANCER

      Breast cancer research and treatment
    69. KLEEBERG UR; DOWSETT M; CARRION RP; DODWELL DJ; VOROBIOF DA; APARICIO LA; ROBERTSON JFR
      A RANDOMIZED COMPARISON OF ESTROGEN SUPPRESSION WITH ANASTROZOLE AND FORMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

      Oncology
    70. FELTON T; SNEAD DRJ; CARTER I; HAINES A; KOLLIAS J; ROBERTSON JFR; ELSTON CW; ELLIS IO
      IDENTIFICATION OF CARCINOMA-CELLS IN PERIPHERAL-BLOOD SAMPLES OF PATIENTS WITH ADVANCED BREAST-CARCINOMA USING RT-PCR AMPLIFICATION OF CK7 AND MUC1

      Journal of pathology
    71. CROMBIE N; PINDER SE; BELL JA; ROBERTSON JFR; BLAMEY RW; ELSTON CW; ELLIS IO
      AN INVESTIGATION OF THE EFFECT OF EXTENT OF DUCTAL CARCINOMA IN-SITU IN INVASIVE-CARCINOMA OF THE BREAST

      Journal of pathology
    72. RALPH C; PINDER SE; ELLIS IO; BELL JA; WENCYK PM; ROBERTSON JFR; BLAMEY RW; ELSTON CW
      PROBABLE VASCULAR INVASION IN INVASIVE BREAST-CARCINOMA - DOES IMMUNOHISTOCHEMISTRY AID IN MORE PRECISE CLASSIFICATION

      Journal of pathology
    73. SNEAD DRJ; GOULDING H; BELL JA; ELSTON CW; ELLIS IO; BLAMEY RW; ROBERTSON JFR; PINDER SE
      COMBINED PROGESTERONE AND ESTROGEN-RECEPTOR (PR AND ER) STATUS IN PREDICTING HORMONE-SENSITIVE BREAST-CANCER - BETTER THAN ER ALONE

      Journal of pathology
    74. ORMANDY CJ; HALL RE; MANNING DL; ROBERTSON JFR; BLAMEY RW; KELLY PA; NICHOLSON RI; SUTHERLAND RL
      COEXPRESSION AND CROSS-REGULATION OF THE PROLACTIN RECEPTOR AND SEX STEROID-HORMONE RECEPTORS IN BREAST-CANCER

      The Journal of clinical endocrinology and metabolism
    75. KOLLIAS J; ELSTON CW; ELLIS IO; ROBERTSON JFR; BLAMEY RW
      EARLY-ONSET BREAST-CANCER - HISTOPATHOLOGICAL AND PROGNOSTIC CONSIDERATIONS

      British Journal of Cancer
    76. CHEUNG KL; WILLSHER PC; ROBERTSON JFR; BAILIE FB; DALY JC; BLAMEY RW
      OMENTAL TRANSPOSITION FLAP FOR GROSS LOCALLY RECURRENT BREAST-CANCER

      Australian and New Zealand journal of surgery
    77. WILLSHER PC; LEACH IH; ELLIS IO; BOURKE JB; BLAMEY RW; ROBERTSON JFR
      A COMPARISON OUTCOME OF MALE BREAST-CANCER WITH FEMALE BREAST-CANCER

      The American journal of surgery
    78. HUI R; CORNISH AL; MCCLELLAND RA; ROBERTSON JFR; BLAMEY RW; MUSGROVE EA; NICHOLSON RI; SUTHERLAND RL
      CYCLIN D1 AND ESTROGEN-RECEPTOR MESSENGER-RNA LEVELS ARE POSITIVELY CORRELATED IN PRIMARY BREAST-CANCER

      Clinical cancer research
    79. WATSON SA; WILKINSON L; HARDCASTLE JD; ROBERTSON JFR
      THE INHIBITORY EFFECT OF THE ANTI-PROGESTOGEN, MEGESTROL-ACETATE ON THE GROWTH OF GASTROINTESTINAL TUMOR-CELLS

      GI cancer
    80. WILLSHER PC; KAPUCUOGLU N; ELLIS IO; CHAN SY; BLAMEY RW; ROBERTSON JFR
      LOCALLY ADVANCED BREAST-CANCER - BIOLOGICAL FACTORS AND RESPONSE TO RADIOTHERAPY

      Oncology Reports
    81. ROBERTSON JFR
      PROSPECTIVE CONFIRMATION OF A BIOCHEMICAL INDEX FOR MEASURING THERAPEUTIC EFFICACY IN METASTATIC BREAST-CANCER IN A MULTICENTER STUDY

      Breast
    82. HOWELL A; DEFRIEND DJ; ROBERTSON JFR; BLAMEY RW; ANDERSON I; ANDERSON E; SUTCLIFFE FA; WALTON P
      CLINICAL-STUDIES WITH THE SPECIFIC PURE ANTIESTROGEN ICI-182780

      Breast
    83. MCCLELLAND RA; GEE JMW; FRANCIS AB; ROBERTSON JFR; BLAMEY RW; WAKELING AE; NICHOLSON RI
      SHORT-TERM EFFECTS OF PURE ANTIESTROGEN ICI-182780 TREATMENT ON ESTROGEN-RECEPTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA PROTEIN EXPRESSION IN HUMAN BREAST-CANCER

      European journal of cancer
    84. JACOBS E; WATSON SA; HARDCASTLE JD; ROBERTSON JFR
      ESTROGEN AND PROGESTERONE RECEPTORS IN GASTROINTESTINAL CANCER CELL-LINES

      European journal of cancer
    85. WILLSHER PC; ROBERTSON JFR; ARMITAGE NC; MORGAN DAL; NICHOLSON RI; BLAMEY RW
      LOCALLY ADVANCED BREAST-CANCER - LONG-TERM RESULTS OF A RANDOMIZED TRIAL COMPARING PRIMARY-TREATMENT WITH TAMOXIFEN OR RADIOTHERAPY IN POSTMENOPAUSAL WOMEN

      European journal of surgical oncology
    86. HUI R; CORNISH AL; MCCLELLAND RA; ROBERTSON JFR; BLAMEY RW; MUSGROVE EA; NICHOLSON RI; SUTHERLAND RL
      CYCLIN D1 AND ESTROGEN-RECEPTOR GENE-EXPRESSION ARE POSITIVELY CORRELATED IN PRIMARY BREAST-CANCER

      Journal of clinical oncology
    87. WILLSHER PC; BEAVER J; PINDER S; BELL JA; ELLIS IO; BLAMEY RW; ROBERTSON JFR
      PROGNOSTIC-SIGNIFICANCE OF SERUM C-ERBB-2 PROTEIN IN BREAST-CANCER PATIENTS

      Breast cancer research and treatment
    88. CLARKE M; COLLINS R; DAVIES C; GODWIN J; GRAY R; PETO R; ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; ARVELAKIS A; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; PEEK U; OATES GD; POWELL J; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; CIRRINCIONE C; KORZUN A; WEISS RB; WOOD WC; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; HORGAN K; HUGHES L; STEWART HJ; GORDON NH; DAVIS HL; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; ABELOFF MD; CARBONE PC; GLICK J; TORMEY DC; ROSSBACH J; SCANLON EF; SCHURMAN S; DESCHRYVER A; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLEFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVALLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; TASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; AHMANN D; SCHAID DJ; BUZDAR AU; SMITH T; HAKES T; NORTON L; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; BROWN A; FISHER B; REDMOND C; WOLMARK N; JACKSON IM; PALMER MK; INGLE JN; SUMAN VJ; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; NAKAMURA Y; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MYLES JD; PATER JL; PRITCHARD KI; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST A; CROSSLEY E; DURRANT K; HARRIS A; BEIGHTON A; COLLINS R; EVANS V; GREAVES E; HARWOOD C; JAMES S; LAU E; MEAD G; MULDAL A; NAUGHTON A; TOOTH A; WHEATLEY K; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPEILMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CJ; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; HOST H; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; FORREST APM; JACK W; MCDONALD C; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; JAKESZ R; GNANT M; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
      OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS

      Lancet
    89. BURRELL HC; SIBBERING DM; WILSON ARM; PINDER SE; EVANS AJ; YEOMAN LJ; ELSTON CW; ELLIS IO; BLAMEY RW; ROBERTSON JFR
      SCREENING INTERVAL BREAST CANCERS - MAMMOGRAPHIC FEATURES AND PROGNOSTIC FACTORS

      Radiology
    90. GONZALEZ MA; PINDER SE; BELL JA; WENCYK PM; ELSTON CW; ROBERTSON JFR; BLAMEY RW; ELLIS IO
      EXPRESSION OF E-CADHERIN, ALPHA-CATENIN AND BETA GAMMA-CATENIN, ALPHA-2-INTEGRIN AND BETA-1-INTEGRIN IN BREAST-CANCER/

      Journal of pathology
    91. PURNELL RM; PINDER SE; WENCYK PM; BELL JA; ELSTON CW; ROBERTSON JFR; ELLIS IO
      DETERMINATION OF C-ERBB-2 GENE AMPLIFICATION USING FLUORESCENT IN-SITU HYBRIDIZATION (FISH) IN INVASIVE BREAST-CANCER

      Journal of pathology
    92. COPE P; PINDER SE; BELL JA; WENCYK PM; ELLIS IO; ROBERTSON JFR; BLAMEY RW; ELSTON CW
      A COMPARISON OF MOLECULAR MARKERS IN PHYLLODES TUMORS AND FIBROADENOMAS

      Journal of pathology
    93. TRAVIS A; PINDER SE; ROBERTSON JFR; BELL JA; WENCYK P; GULLICK WJ; NICHOLSON RI; POLLER DN; BLAMEY RW; ELSTON CW; ELLIS IO
      C-ERBB-3 IN HUMAN BREAST-CARCINOMA - EXPRESSION AND RELATION TO PROGNOSIS AND ESTABLISHED PROGNOSTIC INDICATORS

      British Journal of Cancer
    94. HOWELL A; DEFRIEND DJ; ROBERTSON JFR; BLAMEY RW; ANDERSON L; ANDERSON E; SUTCLIFFE FA; WALTON P
      PHARMACOKINETICS, PHARMACOLOGICAL AND ANTITUMOR EFFECTS OF THE SPECIFIC ANTIESTROGEN ICI-182780 IN WOMEN WITH ADVANCED BREAST-CANCER

      British Journal of Cancer
    95. ROBERTSON JFR
      ESTROGEN-RECEPTOR - A STABLE PHENOTYPE IN BREAST-CANCER

      British Journal of Cancer
    96. POOLE GH; WILLSHER PC; PINDER SE; ROBERTSON JFR; ELSTON CW; BLAMEY RW
      DIAGNOSIS OF BREAST-CANCER WITH CORE-BIOPSY AND FINE-NEEDLE ASPIRATION CYTOLOGY

      Australian and New Zealand journal of surgery
    97. ROBERTSON JFR; CANNON PM; ELLIS IO; BELL J; NICHOLSON RI; ELSTON CW; BLAMEY RW
      PROGNOSTIC VALUE OF IMMUNOCYTOCHEMISTRY OF THE PRIMARY TUMOR IN PATIENTS WITH METASTATIC BREAST-CANCER

      Breast
    98. SIBBERING DM; BURRELL HC; EVANS AJ; YEOMAN LJ; WILSON ARM; ROBERTSON JFR
      MAMMOGRAPHIC SENSITIVITY IN WOMEN UNDER 50 YEARS PRESENTING SYMPTOMATICALLY WITH BREAST-CANCER

      Breast
    99. ROBERTSON JFR
      ABSTRACTS - THE ROLE OF SERUM TUMOR-MARKERS IN BREAST-CANCER - REPORTON A WORKSHOP HELD ON 5 AND 6 MAY 1994 AT THE CITY-HOSPITAL, NOTTINGHAM, UK

      Breast
    100. SIBBERING DM; GALEA MH; MORGAN DAL; ELSTON CW; ELLIS IO; ROBERTSON JFR; BLAMEY RW
      SAFE SELECTION CRITERIA FOR BREAST-CONSERVATION WITHOUT RADICAL EXCISION IN PRIMARY OPERABLE INVASIVE BREAST-CANCER

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:02:14